TherapeuticsMD (TXMD) EBIT Margin (2009 - 2026)
TherapeuticsMD's EBIT Margin came in at -93.90% for Q2 2026, down 20.90 percentage points from -73.00% a year earlier but up 5.96 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) EBIT Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TherapeuticsMD reported EBIT Margin of -120.89%, up 26.12 percentage points year-over-year; for FY2025, it came in at -145.27%, up 201.81 percentage points from FY2024.
- EBIT Margin carries a five-year change of +94.50 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was -347.08% in FY2024 (+307.53 pp), -654.61% in FY2023 (-656.31 pp), 1.70% in FY2022 (+3094.47 pp) and -3092.77% in FY2021 (-2853.01 pp).
- The five-year range for quarterly EBIT Margin is -4269.25% (Q2 2022) to 70.65% (Q4 2022).
- Year-over-year, EBIT Margin increased in six of the last eight quarters, with an average year-over-year change of +593.18 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2023 (a gain of 3703.58 percentage points), and the weakest in Q2 2022 (a drop of 4116.31 percentage points).
- Business Quant data shows TXMD's EBIT Margin at -99.86% (Q1 2026), -173.80% (Q4 2025) and -109.95% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | -93.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.90% |
| Mar 31, 2026 | -99.86% |
| Dec 31, 2025 | -173.80% |
| Sep 30, 2025 | -109.95% |
| Jun 30, 2025 | -73.00% |
| Mar 31, 2025 | -325.95% |
| Dec 31, 2024 | -97.75% |
| Sep 30, 2024 | -207.31% |
| Jun 30, 2024 | -1,191.88% |
| Mar 31, 2024 | -364.86% |
| Dec 31, 2023 | -320.92% |
| Sep 30, 2023 | -3,345.28% |
| Jun 30, 2023 | -565.68% |
| Mar 31, 2023 | -641.11% |
| Dec 31, 2022 | 70.65% |
| Sep 30, 2022 | -4,101.41% |
| Jun 30, 2022 | -4,269.25% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | -189.48% |
| Sep 30, 2021 | -157.13% |
API Access
TherapeuticsMD EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();